Serial #88907295
LIVE

Serial Number

88907295

Owner

Aurinia Pharmaceuticals Inc.

Attorney

Matthew R. Wilmot

Filing Date

May 8, 2020

Add to watchlist:

No watchlists yet
View on USPTO

Serial #88907295 Trademark

Serial Number: 88907295

Serial #88907295 is a trademark filed by Aurinia Pharmaceuticals Inc. on May 8, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Aurinia Pharmaceuticals Inc.

1203-4464 Markham Street
Victoria, BC V8Z7X8 , CA

Entity Type: 11

Trademark Details

Filing Date

May 8, 2020

Registration Date

Not Registered

Goods & Services

Pharmaceutical preparations for the treatment of kidney diseases and disorders, autoimmune diseases and disorders, inflammatory diseases and disorders, and opthamalogical diseases and disorders; pharmaceutical preparations for the treatment of kidney disorders, lupus nephritis, and focal segmental glomerulosclerosis

Filing History

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
May 22, 2026 GNS2
INQUIRY TO SUSPENSION E-MAILED
May 22, 2026 GNSI
SUSPENSION INQUIRY WRITTEN
May 22, 2026 CNSI
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Aug 22, 2025 RCSC
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Aug 21, 2025 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 20, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 20, 2025 GNSL
SUSPENSION LETTER WRITTEN
Feb 20, 2025 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 13, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 13, 2025 CRFA
ASSIGNED TO LIE
Feb 12, 2025 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Feb 7, 2025 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Dec 4, 2024 GNS2
INQUIRY TO SUSPENSION E-MAILED
Dec 4, 2024 GNSI
SUSPENSION INQUIRY WRITTEN
Dec 4, 2024 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jan 25, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Jan 25, 2024 GNSL
SUSPENSION LETTER WRITTEN
Jan 25, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 25, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 11, 2023 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jul 11, 2023 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Apr 18, 2023 GNS2
INQUIRY TO SUSPENSION E-MAILED
Apr 18, 2023 GNSI
SUSPENSION INQUIRY WRITTEN
Apr 18, 2023 CNSI
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Oct 19, 2022 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Apr 19, 2022 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Oct 13, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
Oct 13, 2021 GNSL
SUSPENSION LETTER WRITTEN
Oct 13, 2021 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 13, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 13, 2021 CRFA
ASSIGNED TO LIE
Oct 12, 2021 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Oct 6, 2021 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Apr 21, 2021 GNS2
INQUIRY TO SUSPENSION E-MAILED
Apr 21, 2021 GNSI
SUSPENSION INQUIRY WRITTEN
Apr 21, 2021 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Oct 10, 2020 GNS3
LETTER OF SUSPENSION E-MAILED
Oct 10, 2020 GNSL
SUSPENSION LETTER WRITTEN
Oct 10, 2020 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 9, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 8, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 8, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 29, 2020 GNRN
NON-FINAL ACTION E-MAILED
Jun 29, 2020 GNRT
NON-FINAL ACTION WRITTEN
Jun 29, 2020 CNRT
ASSIGNED TO EXAMINER
Jun 25, 2020 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
May 21, 2020 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 20, 2020 NWOS
NEW APPLICATION ENTERED
May 12, 2020 NWAP